top of page

Deborah C. Mash, PhD

Scientific Advisor (Ibogaine)

Miami-based Deborah Mash is one of the world’s foremost experts on the hallucinogenic drug Ibogaine. She is nationally recognized as a leading researcher in the fields of addiction neurobiology, genomics, and psychedelic medicine, playing a pivotal role in over 300 published studies. She has held uninterrupted NIH funding for over thirty years.   She is the CEO and Founder of DemeRx Inc., a clinical stage drug development company advancing noribogaine for the treatment for alcohol use disorder. 

 

Professor Mash received her Ph.D. in Neuropharmacology from the University of Miami Leonard M. Miller School of Medicine. She completed a fellowship in Neurology and Neuroanatomy at Beth Israel Hospital, Harvard Medical School. She is Professor Emerita of Neurology and Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine.   Dr. Mash serves on the Scientific Advisory Board of Cure Addiction Now.

cid_3A5ED3D1-0F9F-4608-ACED-885504FC1BD8.jpeg
bottom of page